Get our free email newsletter

FDA Issues Guidance on ISO 10993-1 for Medical Device Biological Evaluation

The U.S. Food and Drug Administration (FDA) has issued a guidance document on the use of ISO 10993-1 in the assessment of medical devices that come in direct or indirect contact with the human body.

ISO 10993-1, Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process, is intended to determine the extent to which direct or indirect contact with a medical device has the potential to induce an unacceptable biological response on the part of the patient. The standard is an FDA-recognized consensus standard and can be used to demonstrate compliance with the FDA’s safety requirements in premarket applications (PMAs), humanitarian device exceptions (HDEs) and investigational device applications (IDAs) submitted to the agency.

According to the FDA, the guidance provides further clarification and updated information on the use of the standard. The guidance also incorporates several new considerations, including the use of risk-based approaches in assessing biocompatibility in devices and components.

- Partner Content -

A Dash of Maxwell’s: A Maxwell’s Equations Primer – Part Two

Maxwell’s Equations are eloquently simple yet excruciatingly complex. Their first statement by James Clerk Maxwell in 1864 heralded the beginning of the age of radio and, one could argue, the age of modern electronics.

Read the full text of the FDA’s guidance on the use of ISO 10993-1.

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.